MAP2 Antikörper (AA 1-120)
-
- Target Alle MAP2 Antikörper anzeigen
- MAP2 (Microtubule-Associated Protein 2 (MAP2))
-
Bindungsspezifität
- AA 1-120
-
Reaktivität
- Human, Maus, Ratte, Schwein
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAP2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus, Schwein, Ratte
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human MAP2
- Isotyp
- IgG
- Top Product
- Discover our top product MAP2 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
AMP-activated protein kinase activation in mediating phenylalanine-induced neurotoxicity in experimental models of phenylketonuria." in: Journal of inherited metabolic disease, (2018) (PubMed).
: "Establishment of a novel three-dimensional primary culture model for hippocampal neurogenesis." in: Physiological reports, Vol. 5, Issue 12, (2017) (PubMed).
: "Neuroprotective effects of Wnt/β-catenin signaling pathway against Aβ -induced tau protein over-phosphorylation in PC12 cells." in: Biochemical and biophysical research communications, Vol. 471, Issue 4, pp. 628-32, (2016) (PubMed).
: "Existence of glia mitigated ketamine-induced neurotoxicity in neuron-glia mixed cultures of neonatal rat cortex and the glia-mediated protective effect of 2-PMPA." in: Neurotoxicology, Vol. 44, pp. 218-30, (2014) (PubMed).
: "Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi." in: Journal of neuroinflammation, Vol. 10, pp. 109, (2013) (PubMed).
: "The expression of FOXJ1 in neurogenesis after transient focal cerebral ischemia." in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, Vol. 40, Issue 3, pp. 403-9, (2013) (PubMed).
: "
-
AMP-activated protein kinase activation in mediating phenylalanine-induced neurotoxicity in experimental models of phenylketonuria." in: Journal of inherited metabolic disease, (2018) (PubMed).
-
- Target
- MAP2 (Microtubule-Associated Protein 2 (MAP2))
- Andere Bezeichnung
- MAP2/MAP-2a.b.c (MAP2 Produkte)
- Synonyme
- MAP2A antikoerper, MAP2B antikoerper, MAP2C antikoerper, MAP2R antikoerper, Mtap2 antikoerper, MAP-2 antikoerper, Mtap-2 antikoerper, xmap2 antikoerper, MGC53131 antikoerper, a730034c02 antikoerper, zgc:103474 antikoerper, zgc:113974 antikoerper, microtubule associated protein 2 antikoerper, microtubule-associated protein 2 antikoerper, microtubule associated protein 2 S homeolog antikoerper, MAP2 antikoerper, Map2 antikoerper, map2.S antikoerper, map2 antikoerper
- Hintergrund
-
Synonyms: MAP2A, MAP2B, MAP2C, Microtubule-associated protein 2, MAP-2, MAP2
Background: The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules.
- Gen-ID
- 4133
- UniProt
- P11137
-